GSK's recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initiative.

The Stevenage campus is one of GSK's two main R&D sites, and also houses the Cell and Gene Therapy Catapult, set up in 2012 with government funding to bridge the gap between scientific research ...

Drugs giant GlaxoSmithKline (GSK) is launching a development plan that is set to create up to 5,000 new jobs. The company is looking to extend its facility in Stevenage, Hertfordshire, where it ...